Prostatype Genomics AB
Genomic classifier test guides prostate cancer treatment decisions for patients.
Oversigt
- 5–9
- Medarbejdere
- 200–299t SEK
- Omsætning
- 2007
- Grundlagt
Beskrivelse
Prostatype Genomics is a specialized biotechnology company focused on improving outcomes for men diagnosed with localized prostate cancer. They provide the Prostatype® Genomic Classifier (PGC™), a next-generation prognostic test developed from extensive research at the Karolinska Institute. This non...